Related Experiment Video
Updated: May 26, 2025
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Childhood dyslipidemia: Clinician management practices in the primary care setting
Katherine N Tom1, Alicia M Polack2, Natasha D De Silva3
1Michael G. DeGroote School of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
Insights
Clinician management of childhood dyslipidemia is infrequent, with rare identification of abnormal lipid levels and limited documentation of management plans. Early intervention and specialist referrals were notably absent in community pediatric care.
Area of Science:
- Pediatrics
- Cardiology
- Public Health
Background:
- Childhood dyslipidemia is a growing concern with long-term cardiovascular implications.
- Early detection and management are crucial for preventing future heart disease.
- Current community-based management practices require evaluation.
Purpose of the Study:
- To describe current clinician management practices for childhood dyslipidemia in a community setting.
- To assess the frequency of key management steps for pediatric dyslipidemia.
- To identify gaps in the care of children with abnormal lipid levels.
Main Methods:
- A descriptive study analyzed medical records of children aged 2-10 with dyslipidemia.
- Data was collected from the TARGet Kids! cohort in Toronto, Canada.
- Trained research assistants documented clinician management of abnormal lipid levels.
Main Results:
- Primary care providers saw all children diagnosed with dyslipidemia.
- Medical history regarding lifestyle and cardiovascular risk factors was frequently obtained (73.6%).
- Clinicians rarely informed families of abnormal lipid levels (1.43%) or documented management plans (0.5%), and did not refer to specialists or initiate statin therapy.
Conclusions:
- Paediatric care providers infrequently identified and initiated early management for childhood dyslipidemia.
- Results highlight a need for better knowledge translation of Canadian clinical practice guidelines.
- Improved implementation of guidelines is necessary for effective pediatric dyslipidemia management.
Objectives:
To describe clinician management practices for childhood dyslipidemia in the community setting.
Methods:
A descriptive study was conducted for children aged 2 to 10 years with dyslipidemia as defined by the National Cholesterol Education Program Expert Panel on Cholesterol in Children criteria. A convenience sample of participants from the TARGet Kids! cohort study (Toronto, Canada) was used. Trained research assistants reviewed participant medical records to document clinician management practices of abnormal lipid levels. The study outcome was the proportion of clinicians engaging in each management practice. Descriptive statistics were completed, reporting the proportion of clinician engagement in management practices.
Results:
All 768 children were seen by primary paediatric care providers after lipid levels identified dyslipidemia. Medical history regarding lifestyle behaviours and cardiovascular risk factors were frequently obtained (n = 565, 73.6%). Physicians rarely informed families about abnormal lipid levels (n = 11, 1.43%). Management plans for abnormal lipid levels were rarely documented (n = 4, 0.5%). Clinicians did not refer to paediatric lipid specialists or initiate statin therapy.
Conclusions:
Paediatric care providers rarely identified and initiated early management for abnormal lipid levels. Our results may inform the need for improved knowledge translation of the recently published Canadian clinical practice update for the detection and management of childhood dyslipidemia.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:18Lipids: Dietary Sources and Requirements
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...